Cancer Guardian Structure & Features
Learn about your genes and how they impact your health
with genetic information on your risk for cancer.
Cancer Guardian participants will have access to a Hereditary Genetic Screening Test to better understand risk for cancer.
This is available to participating Cancer Guardian members and spouses at no additional cost, and parents and parents-in-law at a discounted price.
Second Opinion Pathology Review
Read more about how a Second Opinion Pathology Review can lead to more effective treatment options.
Testing the DNA
of Cancer
If your cancer DNA could talk it could tell us what went wrong and give us the best chance to fix or correct it.
Store Medical
Records Securely
Keeping track of appointments and medical records can be a full-time job.
Your program membership includes a donation to The American Cancer Society. Enrolling 1 million people will result in $600,000 being donated annually.
“Cancer Guardian is a very innovative and much needed program that will undoubtedly make a difference to cancer patients and their families.
Accessing and combining state of the art genomics testing technology with comprehensive patient support is a big step towards more effective treatments and better outcomes.”
Professor David Sidransky, M.D.
Director, Head and Neck Cancer Research | Johns Hopkins University Hospital, Baltimore, MD
What people are saying about Advanced DNA Testing, a part of Cancer Guardian membership, and how it gives them piece of mind for the future.
-
Making Cancer Guardian an integral part of our benefits offering for our own employees, in addition to adding this valuable program to the suite of benefits that we make available to all Keystone clients has been one of the easiest decisions I have made as a CEO.
I think this program could be one of the most personally rewarding things I have ever had the privilege of being a part of in my career. It’s a way to show our employees and our clients how much we care about their well-being.
The WGA team has provided flawless enrollment and administration to our staff and our clients giving us the highest level of confidence in everything they do.
-
Corey had an Advanced DNA Test that determined that she was positive for the mutation ROS-1. This qualified her for targeted therapy, and she was started on the drug, Crizotinib, 3 days later.
As a result, Corey’s cancer went into remission. She takes her precision medicine twice a day, with minimal side-effects, and keeps her cancer in remission. In her own words “I feel like I’m back to the high I was at before, a good place where I could continue my life.”
